Medifast, Inc.
MEDMedifast, Inc. (MED) is a health and weight management company that develops and markets clinically proven, portion-controlled weight loss and health-related products. Founded in 1980, the company operates through a network of direct distribution channels, including its own brand, Medifast, and various other health and wellness brands. Medifast focuses on providing meal replacements, dietary supplements, and related products aimed at supporting healthy lifestyles and weight management.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| November 7, 2023 | $1.65 | 2023-09-18 | 2023-09-19 |
| August 8, 2023 | $1.65 | 2023-06-26 | 2023-06-27 |
| May 9, 2023 | $1.65 | 2023-03-27 | 2023-03-28 |
| February 7, 2023 | $1.64 | 2022-12-19 | 2022-12-20 |
| November 8, 2022 | $1.64 | 2022-09-19 | 2022-09-20 |
Dividends Summary
- Consistent Payer: Medifast, Inc. has rewarded shareholders with 32 dividend payments over the past 7 years.
- Total Returned Value: Investors who held MED shares during this period received a total of $30.04 per share in dividend income.
- Latest Payout: The most recent dividend of $1.65/share was paid 984 days ago, on November 7, 2023.
- Yield & Schedule: MED currently pays dividends quarterly with an annual yield of 64.23%.
- Dividend Growth: Since 2016, the dividend payout has grown by 560.0%, from $0.25 to $1.65.
- Dividend Reliability: MED has maintained or increased its dividend for 32 consecutive payments.
Company News
Research shows that declining estrogen during perimenopause accelerates visceral fat accumulation and lean muscle loss, outcomes that standard weight management programs don't address. A study demonstrates that coach-guided programs achieve up to 10 times more weight loss and 17 times more fat loss compared to self-directed efforts, while retaini...
As the weight loss and diet management market expands toward $45 billion by 2030, marketing terms like 'clinically studied' and 'science-backed' lack standardized definitions, allowing programs to apply them to everything from full randomized controlled trials to single ingredient studies. The article emphasizes that rigorous research should use ...
OPTAVIA released research findings showing that clients using their Optimal Weight 5 & 1 Plan with coach support lost up to 10 times more weight and 17 times more fat compared to self-directed participants. The study highlights the importance of human coaching in weight management programs, with research indicating that higher retention rates dir...
Clinical research demonstrates that structured meal replacement programs produce superior body composition outcomes compared to self-directed weight loss approaches. OPTAVIA's Optimal Weight 5 & 1 Plan achieved 14% visceral fat reduction while preserving 98% of lean mass over 16 weeks. Coach-guided programs showed participants lost up to 10 times...
OPTAVIA, backed by 18 randomized controlled trials and 100+ peer-reviewed publications, demonstrates that its structured meal replacement program reduces visceral fat by 14% and preserves 98% of lean mass over 16 weeks. Research shows clients working with coaches lose 10 times more weight and 17 times more fat compared to those without coaching s...
